Loading...
Loading...
Among the 2 tracked institutional investors we monitor, CRDL (CARDIOL THERAPEUTICS INC) is held with a combined value of $1.52M across 1,126,310 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $1.21M (0.00% of their portfolio). RENAISSANCE TECHNOLOGIES LLC opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$1.52M
Total Shares Held
1,126,310
Institutional Holders
2
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $1.21M | 0.00% | +909.6% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $310.24K | 0.00% | New |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of CRDL with a position worth $1.21M, representing 0.00% of their portfolio. In total, 2 institutional investors hold CRDL with a combined value of $1.52M.
In the most recent quarter, 1 fund opened a new position in CRDL. Additionally, 1 increased their holdings.
Institutional investors hold $1.52M worth of CRDL stock across 2 positions. The largest institutional holder is CITADEL ADVISORS LLC with $1.21M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CRDL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CRDL positions.